PDS Biotechnology Corp (PDSB)
2.09
-0.11
(-5.00%)
USD |
NASDAQ |
Nov 22, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Total Assets (Quarterly): 52.45M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 52.45M |
| June 30, 2024 | 60.50M |
| March 31, 2024 | 69.01M |
| December 31, 2023 | 59.39M |
| September 30, 2023 | 57.19M |
| June 30, 2023 | 63.75M |
| March 31, 2023 | 68.45M |
| December 31, 2022 | 77.01M |
| September 30, 2022 | 74.89M |
| June 30, 2022 | 56.00M |
| March 31, 2022 | 61.04M |
| December 31, 2021 | 67.20M |
| September 30, 2021 | 71.75M |
| June 30, 2021 | 77.39M |
| March 31, 2021 | 27.76M |
| December 31, 2020 | 30.89M |
| September 30, 2020 | 34.45M |
| June 30, 2020 | 20.09M |
| March 31, 2020 | 23.93M |
| December 31, 2019 | 14.49M |
| Date | Value |
|---|---|
| September 30, 2019 | 19.38M |
| June 30, 2019 | 25.80M |
| March 31, 2019 | 31.05M |
| December 31, 2018 | 36.22M |
| September 30, 2018 | 37.67M |
| June 30, 2018 | 47.21M |
| March 31, 2018 | 76.61M |
| December 31, 2017 | 92.62M |
| September 30, 2017 | 101.24M |
| June 30, 2017 | 112.99M |
| March 31, 2017 | 99.90M |
| December 31, 2016 | 110.91M |
| September 30, 2016 | 116.58M |
| June 30, 2016 | 115.42M |
| March 31, 2016 | 123.77M |
| December 31, 2015 | 134.09M |
| September 30, 2015 | 58.48M |
| June 30, 2015 | 62.69M |
| December 31, 2014 | 16.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.49M
Minimum
Dec 2019
77.39M
Maximum
Jun 2021
53.38M
Average
59.94M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
| Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.45M |
| Shareholders Equity (Quarterly) | 22.00M |